#alzheimers-research
#alzheimers-research

[ follow ]

Sir Keir Starmer hails legendary' John Prescott ahead of funeral

The article discusses both The Independent's commitment to journalism and the funeral of John Prescott, emphasizing the importance of remembering legacy.

I'm 74 and just finished my 2nd solo row across the Atlantic. I wasn't a sporty kid, but got fit in my 30s.

Frank Rothwell, at 74, found his passion for adventure late in life, transitioning from sailing to solo rowing across the Atlantic.

The Country Doctor' Who Upended Our Understanding of Dementia

Dr. Francisco Lopera's pioneering work in Alzheimer's research was characterized by his deep commitment to understanding familial and genetic links to dementia.

How long COVID could lift the fog on neurocognitive disorders

Long COVID's neurocognitive symptoms significantly impact daily life, comparable to age-related cognitive impairments.

Current understanding and research on cognitive impairment related to COVID-19 require urgent attention.

The Country Doctor' Who Upended Our Understanding of Dementia

Dr. Francisco Lopera's pioneering work in Alzheimer's research was characterized by his deep commitment to understanding familial and genetic links to dementia.

How long COVID could lift the fog on neurocognitive disorders

Long COVID's neurocognitive symptoms significantly impact daily life, comparable to age-related cognitive impairments.

Current understanding and research on cognitive impairment related to COVID-19 require urgent attention.

morepublic-health

Citadel CEO Ken Griffin just donated $50M to Baptist Health. What it means for patients

Ken Griffin donated $50 million to Baptist Health South Florida for Alzheimer's and other disorders.

The donation is the largest in Baptist Health South Florida's history and will fund a new neuroscience center.

#clinical-trials

Where the future of Alzheimer's drugs is heading

The latest Alzheimer's drugs have limited effectiveness and potential serious side effects, prompting researchers to explore new options.

Mesulam Center Celebrates 30th Annual Alzheimer Day: Recognizing Scientific Achievement and Bringing Awareness to Early-Onset Dementia

The Mesulam Center for Cognitive Neurology and Alzheimer's Disease is actively involved in researching Alzheimer's, including recent pharmaceutical breakthroughs like Lecanamab and Donanemab.

Where the future of Alzheimer's drugs is heading

The latest Alzheimer's drugs have limited effectiveness and potential serious side effects, prompting researchers to explore new options.

Mesulam Center Celebrates 30th Annual Alzheimer Day: Recognizing Scientific Achievement and Bringing Awareness to Early-Onset Dementia

The Mesulam Center for Cognitive Neurology and Alzheimer's Disease is actively involved in researching Alzheimer's, including recent pharmaceutical breakthroughs like Lecanamab and Donanemab.

moreclinical-trials

Alzheimer's scientist indicted for allegedly falsifying data in $16M scheme

An Alzheimer's researcher allegedly falsified data to secure $16 million in research funding for an Alzheimer's drug, raising doubts about the integrity of the research.

The investigation revealed long-standing and egregious misconduct in data management by the researcher, leading to questions about the authenticity of the work.

[ Load more ]